Home›Stock Screener›Lincoln Pharmaceuticals›P/E Ratio

Lincoln Pharmaceuticals P/E Ratio

Current P/E Ratio
13.56
Low Valuation
Low - May indicate good value opportunity

Lincoln Pharmaceuticals (LINCOLN) P/E ratio is 13.56 (Low), EPS (TTM) ₹43.88, current price ₹580.00 on NSE vs historical average P/E of 11.15 (80.0th percentile) — Low - May indicate good value opportunity. See LINCOLN P/B ratio history to compare market price against book value per share.

Current Valuation Metrics

P/E Ratio 13.56
Current Price ₹580.00
EPS (TTM) ₹43.88
Exchange NSE

Valuation Signal

Signal Fairly Valued
Historical Avg 11.15
Historical Range 6.87 - 19.54
Percentile 80.0%

Sector Context

Sector Average 55.86
Sector Median 31.44
Sector Rank #11 of 194
Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹35.39
Mar 2026 ₹5.81
Sept 2025 ₹9.98

LINCOLN P/E Ratio — Valuation Signal & Historical Context

Lincoln Pharmaceuticals P/E 13.56 vs historical average 11.15, range 6.87–19.54 — signal: Fairly Valued. Read LINCOLN dividend payout details for the complete payout history and dividend yield track record.

  • Stock appears undervalued with PE of 13.56, suggesting potential buying opportunity
  • Current PE is 21.6% above historical average
  • Trading at discount to sector average PE of 55.86

Lincoln Pharmaceuticals P/E Ratio Historical Trend

LINCOLN annual price-to-earnings ratio — 10 years, EPS and year-end price. Current P/E 13.56 vs historical average 11.15. For live price, revenue and the complete fundamental profile, see LINCOLN share price screener.

LINCOLN Historical P/E Ratio — EPS, Year-End Price & Valuation

Lincoln Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 19.54 43.86 ₹857.05 NSE Moderate
2024 14.38 44.62 ₹641.45 NSE Low
2023 8.26 43.57 ₹360.05 NSE Low
2022 10.2 35.62 ₹363.45 NSE Low
2021 6.87 35.43 ₹243.25 NSE Low
2020 6.99 29.29 ₹204.85 NSE Low
2019 8.87 25.5 ₹226.15 NSE Low
2018 10.13 23.52 ₹238.35 NSE Low
2017 12.87 14.56 ₹187.35 NSE Low
2016 13.42 18.14 ₹243.45 NSE Low

LINCOLN vs Healthcare Peers — P/E Ratio Comparison

Lincoln Pharmaceuticals P/E 13.56 vs Healthcare average 55.86, median 31.44 — range 2.86–916.67.

Sector Average
55.86
Sector Median
31.44
Lowest P/E
2.86
Highest P/E
916.67
Companies
194
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.61 ₹64 Low
Sunrest Lifescience SUNREST 3.76 ₹30 Low
Sun Pharma Advanced Rese… SPARC 4.76 ₹7,399 Low
Shelter Pharma SHELTER 5.23 ₹47 Low
Dipna Pharmachem DPL 5.39 ₹14 Low
JFL Life Sciences JFLLIFE 5.41 ₹68 Low
Amwill Health Care AMWILL 7.26 ₹83 Low
Zenith Drugs ZENITHDRUG 7.69 ₹84 Low
Galaxy Medicare GML 7.8 ₹27 Low